Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring
<p>Abstract</p> <p>Background</p> <p>The ABC transporter P-glycoprotein (P-gp) is recognized as a site for drug-drug interactions and provides a mechanistic explanation for clinically relevant pharmacokinetic interactions with digoxin. The question of whether several P-...
Main Authors: | Michaëlsson Karl, Artursson Per, Hallberg Pär, Englund Gunilla, Melhus Håkan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-04-01
|
Series: | BMC Medicine |
Online Access: | http://www.biomedcentral.com/1741-7015/2/8 |
Similar Items
-
DIGOXIN TOXICITY IN THERAPEUTIC SERUM LEVELS
by: Ugur Arslantas, et al.
Published: (2015-09-01) -
Serum 25-Hydroxyvitamin D Concentrations and Major Depression: A Mendelian Randomization Study
by: Karl Michaëlsson, et al.
Published: (2018-12-01) -
MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. F. Zadvorev, et al.
Published: (2018-05-01) -
Effects of Age, Gender, and Comorbid Diseases on Serum Digoxin Levels During Digoxin Treatment
by: Zeynep ÖZTÜRK, et al.
Published: (2018-01-01) -
Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
by: Antonella Colella, et al.
Published: (2022-06-01)